Cheat sheet

ANCC CV-BC Cheat Sheet

Practice this exam

Assessment and Diagnosis

  • 22% of exam
  • Hemodynamic Normals Infarct Leads STEMI ECG Criteria Heart Sounds Cardiac Labs ABI Values

Planning and Implementation

  • 35% of exam
  • HFrEF Four Pillars ACS Time Targets Antithrombotics Anticoagulation Targets Procedures and Devices Cath Access Care

Evaluation and Modification

  • 18% of exam
  • Drug Interactions Adverse Events Emergency Thresholds Hemodynamic Profiles

Patient and Community Education

  • 25% of exam
  • BP Categories Lifestyle Targets Home Monitoring Community Resources

Quick Facts

  • Exam ANCC CV-BC
  • Credential Cardiac-Vascular Nurse, Board Certified
  • Questions 150 total; 125 scored
  • Time 3 hours
  • Pass 350 scaled of 500
  • Pass rate 67% first-time (2025)
  • Fee $395; $295 ANA member
  • Valid 5 years
  • Retest 60 days; 3 yearly
  • Renewal 75 CE hours
  • Blueprint Dec 5, 2024

Infarct Lead Groups AS

  • II, III, aVF = inferior = right coronary
  • V1-V2: septal V3-V4: anterior I, aVL, V5-V6: lateral V7-V9: posterior

STEMI vs NSTEMI AS

STEMI

  • Complete occlusion
  • Persistent ST elevation
  • Immediate reperfusion

NSTEMI

  • Partial occlusion
  • ST depression or inversion
  • Troponin positive
  • Elevation means immediate reperfusion

Chest Pain Triage AS

  • New chest discomfort → 12-lead within 10 minutes ( First action )
  • ST elevation present → Activate STEMI team ( Start clock )
  • Depression, troponin positive → NSTEMI pathway ( Risk stratify )
  • Normal ECG and troponin → Serial troponin, monitor ( 0/1-hour protocol )
  • Inferior ST elevation → Add right-sided leads ( Check V4R )
  • Tearing pain, unequal pulses → Suspect aortic dissection ( No fibrinolytics )
  • Took PDE5 inhibitor → Withhold nitroglycerin ( 24 to 48 hours )

Hemodynamic Normals AS

  • Cardiac output 4-8 L/min
  • Cardiac index 2.5-4.0 L/min/m2 Under 2.2 hypoperfusion
  • CVP 2-8 mm Hg Right preload
  • PAOP / PCWP 6-12 mm Hg Over 18 congestion
  • PA pressure 15-30/8-15 mm Hg
  • MAP 70-105 mm Hg Shock target 65
  • SVR 800-1200 dynes-s/cm5
  • Stroke volume index 33-47 mL/beat/m2

Acute Limb Ischemia AS

  • Pain, Pallor, Pulseless, Paresthesia, Paralysis, Poikilothermia
  • Pulseless: surgical emergency Paralysis: late sign Time is limb

Stable vs Unstable Angina AS

Stable

  • Predictable exertion trigger
  • Relieved by rest
  • Normal troponin

Unstable

  • New or rest pain
  • Not relieved by rest
  • Normal troponin, still ACS
  • Pattern change means ACS

Infarct Leads AS

  • V1-V2 Septal; LAD
  • V3-V4 Anterior; LAD
  • I, aVL, V5-V6 Lateral; circumflex
  • II, III, aVF Inferior; right coronary
  • V7-V9 Posterior; circumflex or RCA
  • V4R Right ventricle; proximal RCA Preload dependent
  • aVR elevation Left main or multivessel

Right vs Left Heart Failure AS

Right sided

  • JVD, hepatomegaly
  • Ascites, dependent edema
  • Hepatojugular reflux

Left sided

  • Crackles, orthopnea
  • Exertional dyspnea
  • Paroxysmal nocturnal dyspnea
  • Systemic vs pulmonary congestion

STEMI ECG Criteria AS

  • Most leads 1 mm, two contiguous
  • V2-V3, men 40+ 2 mm elevation
  • V2-V3, men under 40 2.5 mm elevation
  • V2-V3, women 1.5 mm elevation
  • Measured at J point
  • Reciprocal change Depression in opposite wall
  • New LBBB Not automatic STEMI; apply Sgarbossa

S3 vs S4 AS

S3

  • Early diastole
  • Volume overload
  • Decompensated heart failure

S4

  • Late diastole
  • Stiff ventricle
  • Absent in atrial fibrillation
  • Volume vs stiffness

Heart Sounds AS

  • S3 Early diastole; volume overload
  • S4 Stiff ventricle; absent in AF
  • Aortic stenosis Systolic; radiates to carotids
  • Aortic regurgitation Diastolic; wide pulse pressure
  • Mitral regurgitation Holosystolic; radiates to axilla
  • Mitral stenosis Diastolic rumble; opening snap
  • Mitral valve prolapse Mid-systolic click
  • Pericardial rub Scratchy; better leaning forward
  • Pulsus paradoxus Tamponade; drop over 10

Cardiac Labs AS

  • hs-troponin Injury; needs rise or fall 0/1-hour protocol
  • BNP Wall stress; rules out HF
  • NT-proBNP Usable on sacubitril/valsartan
  • D-dimer Sensitive, not specific
  • INR Warfarin effect
  • aPTT Unfractionated heparin monitoring
  • Anti-Xa Heparin or LMWH level
  • Potassium MRA and ACE inhibitor safety
  • Creatinine clearance DOAC dosing

ABI Values AS

  • Calculation Ankle divided by brachial
  • 1.00-1.40 Normal
  • 0.91-0.99 Borderline
  • 0.90 or less Peripheral artery disease
  • 0.40 or less Severe ischemia; rest pain
  • Above 1.40 Noncompressible; use toe pressure

HFrEF Four Pillars PL

  • ARNI + beta-blocker + MRA + SGLT2 inhibitor
  • ARNI: sacubitril/valsartan Beta-blocker: carvedilol MRA: spironolactone SGLT2i: dapagliflozin

HFrEF vs HFpEF PL

HFrEF

  • LVEF 40% or less
  • Dilated, weak pump
  • Four-pillar GDMT

HFpEF

  • LVEF 50% or more
  • Stiff, poor filling
  • SGLT2i, diuretic, comorbidities
  • Weak pump vs stiff

STEMI Reperfusion Pathway PL

  • At PCI-capable hospital → Primary PCI, 90 minutes
  • Transfer under 120 minutes → Transfer for primary PCI
  • PCI beyond 120 minutes → Fibrinolysis, 30 minutes
  • Onset beyond 12 hours → PCI, not fibrinolysis
  • Prior intracranial hemorrhage → Fibrinolysis contraindicated ( Absolute )
  • Cardiogenic shock → Immediate invasive strategy
  • After reperfusion → DAPT, statin, beta-blocker

HFrEF Four Pillars PL

  • ARNI Sacubitril/valsartan preferred
  • Beta-blocker Carvedilol, metoprolol succinate, bisoprolol
  • MRA Spironolactone or eplerenone
  • SGLT2 inhibitor Dapagliflozin or empagliflozin
  • Loop diuretic Congestion; no mortality benefit
  • ARNI washout 36 hours off ACE inhibitor
  • HFrEF LVEF 40% or less
  • HFmrEF LVEF 41-49%
  • HFpEF LVEF 50% or more

CHA2DS2-VASc Score PL

  • CHF, HTN, Age, Diabetes, Stroke, Vascular, Sex
  • Age 75 or older: 2 Stroke or TIA: 2 All others: 1 point Treat 2 men, 3 women

Warfarin vs DOAC PL

Warfarin

  • Routine INR monitoring
  • Vitamin K interactions
  • Vitamin K, 4F-PCC

DOAC

  • No routine monitoring
  • Renal and weight dosing
  • Idarucizumab, andexanet alfa
  • Monitor INR vs renal dosing

Choosing HF GDMT PL

  • LVEF 40% or less → Start four pillars
  • Already on ACE inhibitor → Switch to ARNI ( 36-hour washout )
  • ARNI not feasible → ACE inhibitor or ARB
  • Potassium under 5.0 → Add MRA ( eGFR above 30 )
  • On other pillars → Add SGLT2 inhibitor ( Diabetes not required )
  • Volume overloaded → Add loop diuretic ( Symptoms only )
  • LVEF 35% after months → Refer for ICD ( 40 days post-MI )
  • LBBB, QRS 150 ms → Add CRT

ACS Time Targets PL

  • First ECG Within 10 minutes
  • Primary PCI 90 minutes from contact
  • Transfer for PCI 120 minutes from contact
  • Fibrinolysis Door-to-needle 30 minutes
  • Fibrinolysis window Within 12 hours onset
  • Troponin protocol 0/1 or 0/2 hours
  • Access preference Radial over femoral
  • High-intensity statin Started during hospitalization

Cardioversion vs Defibrillation PL

Synchronized

  • Pulse present
  • AF, SVT, monomorphic VT
  • Timed to R wave

Unsynchronized

  • Pulseless patient
  • VF, pulseless VT
  • Polymorphic VT
  • Pulse means synchronize

AF Stroke Prevention PL

  • New atrial fibrillation → Score CHA2DS2-VASc
  • Score 2 men, 3 women → Anticoagulate ( Risk 2% yearly )
  • No mechanical valve → DOAC over warfarin
  • Mechanical valve, rheumatic stenosis → Warfarin only
  • AF beyond 48 hours → TEE or 3 weeks
  • Unstable with rapid rate → Synchronized cardioversion
  • Anticoagulation contraindicated → Consider appendage occlusion

Antithrombotics PL

  • Aspirin Irreversible COX-1 blockade
  • Clopidogrel P2Y12 prodrug; CYP2C19
  • Ticagrelor Reversible P2Y12; dyspnea
  • Prasugrel Avoid after stroke or TIA
  • Unfractionated heparin aPTT titrated; reversible
  • Enoxaparin Renally dosed LMWH
  • Bivalirudin Direct thrombin inhibitor
  • Argatroban Anticoagulant of choice, HIT
  • DAPT duration At least 12 months Ticagrelor alone after month

Radial vs Femoral Access PL

Radial

  • Compression band
  • Early ambulation
  • Check hand perfusion

Femoral

  • Supine bed rest
  • Leg kept straight
  • Watch retroperitoneal bleed
  • Radial bleeds less

Anticoagulation Targets PL

  • AF or VTE INR 2.0-3.0
  • Bioprosthetic valve INR 2.0-3.0
  • Mechanical mitral valve INR 2.5-3.5
  • Dabigatran reversal Idarucizumab
  • Factor Xa reversal Andexanet alfa
  • Warfarin reversal Vitamin K, 4F-PCC
  • Heparin reversal Protamine sulfate
  • DOAC monitoring Renal function, not INR

Procedures and Devices PL

  • PCI Stent the culprit lesion
  • CABG Bypass with graft conduits
  • TAVR Transcatheter aortic valve replacement
  • TEER Edge-to-edge mitral repair
  • IABP Inflate diastole, deflate systole
  • LVAD Continuous flow; Doppler MAP
  • ECMO Temporary cardiopulmonary support
  • ICD LVEF 35% or less 40 days post-MI
  • CRT LBBB with QRS 150 ms
  • Severe aortic stenosis Mean gradient 40 mm Hg
  • Severe mitral stenosis Valve area 1.5 cm2

Cath Access Care PL

  • Radial access Band with patent hemostasis
  • Radial checks Color, warmth, sensation, refill
  • Femoral access Supine, leg straight, flat
  • Hematoma Hold pressure; mark border
  • Pseudoaneurysm Pulsatile mass; new bruit
  • Retroperitoneal bleed Back or flank pain
  • Contrast nephropathy Hydrate; trend creatinine

Tamponade Beck Triad EV

  • Hypotension + JVD + muffled heart sounds
  • Pulsus paradoxus over 10 Narrow pulse pressure Pericardiocentesis treats

Hypertensive Urgency vs Emergency EV

Urgency

  • No target organ damage
  • Oral agents
  • Gradual outpatient lowering

Emergency

  • Target organ damage
  • IV titratable agent
  • Lower 25% first hour
  • Organ damage decides

Hemodynamic Profiles EV

  • Warm and dry → Compensated; continue GDMT
  • Warm and wet → IV diuretic, vasodilator
  • Cold and wet → Inotrope plus diuretic
  • Cold and dry → Cautious fluid, then inotrope
  • Index under 2.2, hypotensive → Cardiogenic shock pathway
  • High CVP, clear lungs → Suspect right ventricular infarct

Drug Interactions EV

  • Amiodarone + digoxin Halve the digoxin dose
  • Amiodarone + warfarin INR climbs; reduce dose
  • Nitrate + PDE5 inhibitor Profound refractory hypotension
  • Sildenafil, vardenafil Hold nitrates 24 hours
  • Tadalafil Hold nitrates 48 hours
  • ACE inhibitor to ARNI 36-hour washout
  • MRA + ACE inhibitor Hyperkalemia; recheck potassium
  • Warfarin + vitamin K Consistency, not avoidance
  • Statin + gemfibrozil Rhabdomyolysis risk

Adverse Events EV

  • HIT Platelets fall 50%; thrombosis Day 5-10
  • ACE inhibitor cough Switch to ARB
  • ARNI angioedema Stop drug; secure airway
  • Hyperkalemia Stop MRA above 5.5
  • Digoxin toxicity Nausea, halos, arrhythmia
  • Statin myopathy Muscle pain; check CK
  • Amiodarone toxicity Thyroid, liver, lung, eye
  • IV amiodarone In-line filter; central preferred
  • Warfarin bleeding Hold; vitamin K

Emergency Thresholds EV

  • Hypertensive emergency Lower 25% first hour
  • Aortic dissection Systolic under 120 mm Hg
  • Cardiogenic shock Systolic under 90; hypoperfusion
  • Shock vasopressor Norepinephrine first line
  • Stroke thrombolysis Within 4.5 hours Door-to-needle 60
  • Thrombectomy window Up to 24 hours
  • Post-arrest temperature 32-37.5 degrees Celsius Hold 36 hours
  • Cardiac tamponade Beck triad; pulsus paradoxus
  • High-risk PE Hypotension; consider thrombolysis

Smoking Cessation 5 A's ED

  • Ask, Advise, Assess, Assist, Arrange
  • Ask at every visit Assist: counseling plus drug Arrange follow-up

ACC/AHA Stage vs NYHA Class ED

ACC/AHA stage

  • Structural progression
  • Stages A through D
  • Never moves backward

NYHA class

  • Functional symptoms
  • Class I through IV
  • Can improve or worsen
  • Structure vs symptoms

Education Barrier Picker ED

  • Low health literacy → Teach-back, plain language
  • Vision or dexterity limits → Pill organizer, large print
  • Limited English proficiency → Qualified medical interpreter
  • Cost barrier → Assistance program referral
  • Recent MI or PCI → Refer cardiac rehabilitation
  • Starting warfarin → Anticoagulation clinic referral

BP Categories ED

  • Normal Under 120/80 mm Hg
  • Elevated 120-129 systolic, under 80
  • Stage 1 130-139 or 80-89
  • Stage 2 140 or 90 higher
  • Crisis Above 180/120 mm Hg
  • Treatment goal Under 130/80 mm Hg
  • Risk calculator PREVENT equations

Lifestyle Targets ED

  • Aerobic activity 150 minutes weekly, moderate
  • Vigorous activity 75 minutes weekly
  • Strength training Two or more days
  • Sodium limit Under 2,300 mg daily Optimal 1,500 mg
  • High-intensity statin Lowers LDL 50% or more
  • Post-ACS LDL Add nonstatin at 70
  • Smoking cessation Counseling plus pharmacotherapy
  • Nonmodifiable risks Age, sex, race, family

Home Monitoring ED

  • Daily weight Same scale, after voiding
  • Report weight gain 2-3 pounds overnight, 5 weekly
  • BP technique Rest 5 minutes, bare arm
  • BP readings Two, one minute apart
  • Nitroglycerin rule No relief 5 minutes, 911
  • Symptom action plan Green, yellow, red zones
  • Teach-back Patient explains in own words

Community Resources ED

  • Cardiac rehab Up to 36 supervised sessions
  • Rehab referral MI, PCI, CABG, valve
  • HF rehab coverage LVEF 35% or less
  • Anticoagulation clinic Dosing; time in range
  • Home INR testing Fingerstick point-of-care meter
  • Remote CIED check Lead, battery, fluid trends
  • HF follow-up Visit within 7 days

Common Traps

Injury vs infarction

  • Troponin shows injury ≠ MI needs ischemic evidence

S3 vs S4

  • S3 is volume ≠ S4 is stiffness

Urgency vs emergency

  • Urgency spares organs ≠ Emergency damages organs

Sync vs defibrillate

  • Pulse means synchronize ≠ Pulseless means defibrillate

Rate vs rhythm control

  • Rate slows ventricles ≠ Rhythm restores sinus

Nitrates in RV infarct

  • RV is preload dependent ≠ Nitrates drop pressure abruptly

Vitamin K teaching

  • Consistency, not avoidance ≠ Report every diet change

BNP on ARNI

  • Sacubitril raises BNP ≠ NT-proBNP stays usable

Stage vs class

  • HF stage never reverses ≠ NYHA class can improve

Scored vs pretest

  • 125 questions scored ≠ 25 pretest not scored

Last Minute

  • 1. Planning 35% is largest domain
  • 2. Education 25%; Assessment 22%
  • 3. Evaluation and Modification is 18%
  • 4. 150 questions; only 125 scored
  • 5. Pass = 350 scaled of 500
  • 6. Primary PCI within 90 minutes
  • 7. Fibrinolysis needle within 30 minutes
  • 8. HFrEF pillars: ARNI, BB, MRA, SGLT2i
  • 9. ACE to ARNI = 36-hour washout
  • 10. Anticoagulate CHA2DS2-VASc 2 men, 3 women
  • 11. INR 2-3; mechanical mitral 2.5-3.5
  • 12. ABI 0.90 or less = PAD
  • 13. BP treatment goal under 130/80
  • 14. Report 2-3 pound overnight gain
  • 15. Nitroglycerin: no relief 5 minutes, 911
  • 16. Cardiac rehab: up to 36 sessions
  • 17. Pulse = synchronize; pulseless = defibrillate
  • 18. Hold nitrates after PDE5 inhibitors

CV-BC Cardiac-Vascular Nursing

  • Practice Questions 145 questions Study Guide 33 topics Cheat Sheet 154 facts Flashcards 50 cards Free CE Podcast